Dan Rubinstein

Overview

Dan Rubinstein is an angel investor and the CEO and co-founder of Physera, a company that modernizes musculoskeletal care through direct access to top providers and personalized treatment. Under his leadership, Physera has raised over $58 million and grown to over 60 employees, eventually being acquired by Omada Health. Prior to founding Physera, Rubinstein held significant roles at Palantir, Facebook, and Google, where he gained extensive experience in product and engineering management. He holds a PhD in Statistics from Stanford University and a BS in Electrical Engineering from Princeton University. As an angel investor, Rubinstein focuses on healthcare and technology sectors, particularly in areas such as telehealth, physical therapy, and digital health. His investment strategy emphasizes early-stage companies with innovative solutions that address significant challenges in these industries. He is known for his hands-on approach, leveraging his extensive network and expertise to support portfolio companies in scaling their operations and achieving sustainable growth. Rubinstein's track record reflects a commitment to fostering innovation and improving healthcare delivery through technology. His leadership at Physera exemplifies his ability to build and scale technology-driven companies that have a meaningful impact on society. His experience at leading tech companies provides him with a unique perspective on product development and market dynamics, which he applies to his investment endeavors.

Investment Focus

• Innovative solutions in healthcare and technology sectors
• Strong founding teams with a clear vision
• Scalable business models addressing significant market needs

Portfolio Companies